12-15 Molecular Diagnostics

12-15 Molecular Diagnostics's team is a diverse group of innovators at the cutting edge of science. Dr. Saion Sinha has been leading cutting edge research into difficult scientific problems since he was a student studying physics at the Indian Institute of Technology in Kharagpur, India. He received his PhD from the University of Kentucky and serve... s as a professor and researcher at the University of New Haven. After developing tests for Lyme disease and pioneering a patent for the use of carbon nanowire in testing DNA, Dr. Sinha founded 12-15 Molecular Diagnostics in 2016. The organization has studied a range of airborne disease and viruses in animals. In 2018, the 12-15 team developed the advanced technique of Hybridization, which uses carbon-based nanomaterial to process biofluids electronically. Using this technology, the 12-15 team has developed Veralize, a device that enables a 20 minute saliva test for COVID-19 with 95% sensitivity and accuracy. Veralize is currently applying for FDA approval and expects to have a product on the market by the fourth quarter of 2020. There is a serious need for rapid testing right now. 12-15 Molecular Diagnostics will continue improving 12-15 Molecular Diagnostics's devices. 12-15 Molecular Diagnostics's goal is to keep making a difference in people's lives.Read More